First Oral SMA Treatment Gets EMA Panel Thumbs Up First Oral SMA Treatment Gets EMA Panel Thumbs Up

The CHMP gives positive opinion on risdiplam as the first oral treatment for adults and children at least 2 months of age who have certain types of spinal muscular atrophy.International Approvals
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news